Detalhe da pesquisa
1.
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.
Blood;
143(20): 2099-2105, 2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38483155
2.
CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Lancet Oncol;
21(2): e104-e116, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32007196
3.
Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity.
Allergy;
76(8): 2595-2599, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33764510
4.
National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells.
Transplant Cell Ther;
30(6): 626.e1-626.e11, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38494077
5.
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies.
Transplant Cell Ther;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762057
6.
Expanding access to CAR T cell therapies through local manufacturing.
Nat Biotechnol;
41(12): 1698-1708, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37884746
7.
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis.
Cancer Gene Ther;
30(6): 845-854, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36750666
8.
CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products.
Blood Adv;
7(15): 4124-4134, 2023 08 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37196643
9.
Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
Blood Cancer Discov;
2(5): 408-422, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34568831
10.
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals.
Mol Ther Methods Clin Dev;
18: 269-279, 2020 Sep 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32637456
11.
Linking Scattered Stem Cell-Based Data to Advance Therapeutic Development.
Trends Mol Med;
25(1): 8-19, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30497944
12.
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.
Stem Cells Transl Med;
7(9): 676-685, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30063299